References
- Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006; 3: CD004454
- Edwards A, Baker LS, Wallace EM. Changes in fetoplacental vessel flow velocity waveforms following maternal administration of betamethasone. Ultrasound Obstet Gynecol. 2002; 20: 240–4
- Muller T, Nanan R, Dietl J. Effect of antenatal corticosteroid administration on Doppler flow velocity parameters in pregnancies with absent or reverse end-diastolic flow in the umbilical artery. Acta Obstet Gynecol Scand. 2003; 82: 794–6
- Simchen MJ, Alkazaleh F, Adamson SL, Windrim R, Telford J, Beyene J, et al. The fetal cardiovascular response to antenatal steroids in severe early-onset intrauterine growth restriction. Am J Obstet Gynecol. 2004; 190: 296–304
- Wallace EM, Baker LS. Effect of antenatal betamethasone administration on placental vascular resistance. Lancet. 1999; 353: 1404–7
- Edwards A, Baker LS, Wallace EM. Changes in umbilical artery flow velocity waveforms following maternal administration of betamethasone. Placenta 2003; 24: 12–6
- Kahler C, Schleussner E, Moller A, Seewald HJ. Doppler measurements in fetoplacental vessels after maternal betamethasone administration. Fetal Diagn Ther. 2004; 19: 52–7
- Vonesh EF, Schork MA. Sample sizes in the multivariate analysis of repeated measurements. Biometrics. 1986; 42: 601–10
- Maulik D. Management of fetal growth restriction: an evidence-based approach. Clin Obstet Gynecol. 2006; 49: 320–34
- Francisco RP, Miyadahira S, Zugaib M. Predicting pH at birth in absent or reversed end-diastolic velocity in the umbilical arteries. Obstet Gynecol. 2006; 107: 1042–8
- Clifton VL, Read MA, Leitch IM, Giles WB, Boura AL, Robinson PJ, et al. Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: involvement of the nitric oxide-cyclic guanosine 3′,5′-monophosphate-mediated pathway. J Clin Endocrinol Metab. 1995; 80: 2888–93
- Korebrits C, Yu DH, Ramirez MM, Marinoni E, Bocking AD, Challis JR. Antenatal glucocorticoid administration increases corticotrophin-releasing hormone in maternal plasma. Br J Obstet Gynaecol. 1998; 105: 556–61
- Marinoni E, Korebrits C, Di Iorio R, Cosmi EV, Challis JR. Effect of betamethasone in vivo on placental corticotropin-releasing hormone in human pregnancy. Am J Obstet Gynecol. 1998; 178: 770–8
- Derks JB, Giussani DA, Jenkins SL, Wentworth RA, Visser GH, Padbury JF, et al. A comparative study of cardiovascular, endocrine and behavioural effects of betamethasone and dexamethasone administration to fetal sheep. J Physiol. 1997; 499: 217–26
- Kari MA, Hallman M, Eronen M, Teramo K, Virtanen M, Koivisto M, et al. Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomized placebo-controlled multicenter study. Pediatrics. 1994; 93: 730–6
- Schwab M, Coksaygan T, Nathanielsz PW. Betamethasone effects on ovine uterine and umbilical placental perfusion at the dose used to enhance fetal lung maturation. Am J Obstet Gynecol. 2006; 194: 572–9